文献速递慢性静脉疾病

VIEW-VLU观察性研究:Varithena治疗静脉性腿部溃疡对创面愈合的影响

VIEW-VLU observational study of the effect of Varithena on wound healing in the treatment of venous leg ulcers.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2023-03-25

VIEW-VLU为多中心、开放标签、IV期注册研究,纳入76例(80处溃疡)大隐静脉和/或前副大隐静脉系统功能不全所致活动性静脉性腿部溃疡患者,采用1%聚多卡醇微泡沫化学消融,随访12个月。12周时53.8%溃疡愈合,Kaplan-Meier中位愈合时间89天,愈合后12周88.9%保持闭合。

要点

  • 12周时53.8%(43/80)溃疡愈合,Kaplan-Meier中位愈合时间89天
  • 愈合后12周88.9%保持闭合
  • 疼痛评分12周改善41.0%、12个月改善64.1%

核心结论

  • 1%聚多卡醇微泡沫治疗与静脉性腿部溃疡较好的愈合率和较低的复发率相关,尽管患者溃疡顽固、环周溃疡比例高且体重指数高。

研究设计与样本

  • 多中心、开放标签、IV期注册研究(VIEW-VLU),纳入14个中心76例患者共80处活动性静脉性腿部溃疡,随访12个月。

主要发现

  • 中位创面周长术后2周较基线减少16.3%,12周减少27.0%;12周时53.8%(43/80)溃疡愈合;Kaplan-Meier中位愈合时间89天(95%CI 62.0-117.0)。
  • 愈合溃疡的Kaplan-Meier分析显示,愈合后12周88.9%(95%CI 76.9-94.8)保持闭合。
  • 溃疡部位平均数字疼痛评分术后12周改善41.0%,12个月改善64.1%。
  • 健康相关生活质量指数(0-1)由基线0.65±0.27升至12周0.72±0.28、12个月0.73±0.30。
  • 12周时目标腿静脉临床严重程度评分平均显著下降5.8分,12个月下降10.0分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Chronic venous hypertension, triggered by venous reflux and/or obstruction, leads to skin changes and venous leg ulcers (VLUs). Compression therapy is the standard of care, but many wounds remain unhealed. The objectives of this study were to observe the effects of endovenous chemical ablation with commercially available 1% polidocanol injectable microfoam on VLU healing and recurrence rates. METHODS: The VIEW VLU study was a multicenter, open-label, phase IV registry of patients with active VLUs resulting from venous insufficiency of the great saphenous vein and/or anterior accessory saphenous vein systems who underwent ablation with 1% polidocanol microfoam. Primary outcomes included wound healing rate (change in wound perimeter), wound closure at 12 weeks after treatment, and time to wound closure. Secondary outcomes included VLU recurrence, numeric pain score at the ulcer location, EuroQol five-dimension five-level questionnaire quality-of-life index, and the Venous Clinical Severity Score. Patients were followed for 12 months. RESULTS: We enrolled 76 patients (80 ulcers) from 14 sites across the United States and Canada (mean age 63.6 ± 13.7 years, 39.5% female, mean body mass index 36.3). Of the enrollees, 96.3% presented with great saphenous vein incompetence. The mean baseline wound perimeter was 117.2 ± 107.4 mm and 26.3% of wounds (21/80) were circumferential. The mean ulcer age was 34.8 ± 51.8 weeks at first presentation and the mean compression therapy duration was 26.4 ± 35.9 weeks. The median wound perimeter decreased by 16.3% from baseline in the first 2 weeks after the procedure and by 27.0% at 12 weeks. By 12 weeks, 53.8% of wounds (43/80) were healed. The median time to ulcer closure by Kaplan-Meier analysis was 89 days (95% confidence interval, 62.0-117.0). In a Kaplan-Meier analysis of initially healed wounds, 88.9% (95% confidence interval, 76.9-94.8) remained closed at 12 weeks after closure. The mean numeric pain scores (ulcer site) improved by 41.0% and 64.1% at 12 weeks and 12 months after the procedure, respectively. The health-related quality-of-life index (scale of 0-1) improved from 0.65 ± 0.27 at baseline to 0.72 ± 0.28 at 12 weeks and 0.73 ± 0.30 at 12 months. By 12 weeks after treatment, the mean target leg Venous Clinical Severity Score had significantly decreased by 5.8 points, and by 12 months it had decreased by 10.0 points. CONCLUSIONS: Treatment with 1% polidocanol microfoam was associated with promising wound healing rates and low recurrence rates for VLUs, despite a challenging patient population with recalcitrant ulcers, a large percentage of which were circumferential, in patients with high body mass indexes.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Shao MY, Harlin S, Chan B, et al. VIEW-VLU observational study of the effect of Varithena on wound healing in the treatment of venous leg ulcers. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 36972751. doi:10.1016/j.jvsv.2023.01.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。